Vimarsana
Biggest News Aggregation in the World

Page 14 - Viewray Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Viewray Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Viewray Inc Today - Breaking & Trending Today

ViewRay, Inc. (NASDAQ:VRAY) Receives $2.54 Average PT from Brokerages - Vimarsana News

ViewRay, Inc. (NASDAQ:VRAY) Receives $2.54 Average PT from Brokerages

ViewRay, Inc. (NASDAQ:VRAY – Get Rating) has been assigned a consensus recommendation of “Hold” from the eight ratings firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. The average 1-year price target […]

ViewRay, Inc. (NASDAQ:VRAY) to Post Q2 2023 Earnings of ($0.15) Per Share, B. Riley Forecasts - Vimarsana News

ViewRay, Inc. (NASDAQ:VRAY) to Post Q2 2023 Earnings of ($0.15) Per Share, B. Riley Forecasts

ViewRay, Inc. (NASDAQ:VRAY – Get Rating) – Stock analysts at B. Riley dropped their Q2 2023 earnings per share (EPS) estimates for ViewRay in a research note issued on Thursday, May 11th. B. Riley analyst N. Chatterji now anticipates that the company will post earnings per share of ($0.15) for the quarter, down from their […]

Do You Believe in the Growth Prospects of ViewRay (VRAY)? - Vimarsana News

Do You Believe in the Growth Prospects of ViewRay (VRAY)?

Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.

ViewRay's MRIdian® to be Featured at Leading European Radiation Oncology Meeting - Vimarsana News

ViewRay's MRIdian® to be Featured at Leading European Radiation Oncology Meeting

/PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian MRI-guided radiation therapy system will be featured at the Annual...

ViewRay (NASDAQ:VRAY) Lowered to "Neutral" at B. Riley - Vimarsana News

ViewRay (NASDAQ:VRAY) Lowered to "Neutral" at B. Riley

B. Riley downgraded shares of ViewRay (NASDAQ:VRAY – Get Rating) from a buy rating to a neutral rating in a research report report published on Thursday morning, The Fly reports. The firm currently has $1.00 target price on the stock, down from their previous target price of $4.00. A number of other equities research analysts […]